{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T12:49:52Z","timestamp":1788871792720,"version":"build-2803163510"},"reference-count":144,"publisher":"Informa UK Limited","issue":"1","funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["R21 DK081194 and KO8 HD042172"],"award-info":[{"award-number":["R21 DK081194 and KO8 HD042172"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pediatric Health"],"published-print":{"date-parts":[[2010,2]]},"DOI":"10.2217\/phe.09.69","type":"journal-article","created":{"date-parts":[[2010,1,25]],"date-time":"2010-01-25T06:47:15Z","timestamp":1264402035000},"page":"59-73","source":"Crossref","is-referenced-by-count":10,"title":["Interventional Studies for Polycystic Ovarian Syndrome in Children and Adolescents"],"prefix":"10.2217","volume":"4","author":[{"given":"Patricia Myriam","family":"Vuguin","sequence":"first","affiliation":[{"name":"Children\u2019s Hospital at Montefiore, Albert Einstein College of Medicine, 3450 Bainbridge Ave, Bronx, NY10467, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2010,1,25]]},"reference":[{"key":"e_1_3_2_3_1_1","doi-asserted-by":"publisher","DOI":"10.1196\/annals.1429.005"},{"key":"e_1_3_2_3_2_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1529-8019.2008.00217.x"},{"key":"e_1_3_2_3_3_1","doi-asserted-by":"publisher","DOI":"10.1159\/000101538"},{"key":"e_1_3_2_3_4_1","first-page":"3078","article-title":"Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study.","volume":"83","author":"Knochenhauer ES","year":"1998","unstructured":"Knochenhauer ES , KeyTJ, Kahsar-MillerM, WaggonerW, BootsLR, AzzizR: Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study.J. Clin. Endocrinol. Metab.83, 3078\u20133082(1998).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"e_1_3_2_3_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2008.06.035"},{"key":"e_1_3_2_3_6_1","unstructured":"Zawadski JK DunaifA: Diagnostic Criteria for Polycystic Ovary Syndrome; Towards a Rational Approach. Blackwell Scientific MA USA (1992)."},{"key":"e_1_3_2_3_7_1","first-page":"165","article-title":"Prevalence and predictors of risk for Type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women.","volume":"84","author":"Legro RS","year":"1999","unstructured":"Legro RS , KunselmanAR, DodsonWC, DunaifA: Prevalence and predictors of risk for Type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women.J. Clin. Endocrinol. Metab.84, 165\u2013169(1999).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"e_1_3_2_3_8_1","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.22.1.141"},{"key":"e_1_3_2_3_9_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2006-0178"},{"key":"e_1_3_2_3_10_1","doi-asserted-by":"publisher","DOI":"10.1038\/ijo.2008.61"},{"key":"e_1_3_2_3_11_1","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/14.9.2223"},{"key":"e_1_3_2_3_12_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.1997.tb52143.x"},{"key":"e_1_3_2_3_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.mce.2006.04.028"},{"key":"e_1_3_2_3_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2006.04.015"},{"key":"e_1_3_2_3_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.beem.2006.02.005"},{"key":"e_1_3_2_3_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.beem.2006.02.002"},{"key":"e_1_3_2_3_17_1","article-title":"Characteristics of adolescents presenting to a multidisciplinary clinic for polycystic ovarian syndrome.","author":"Tracy Bekx M","year":"2009","unstructured":"Tracy Bekx M , ConnorEC, AllenDB: Characteristics of adolescents presenting to a multidisciplinary clinic for polycystic ovarian syndrome.J. Pediatr. Adolesc. Gynecol. (2009) (Epub ahead of print).","journal-title":"J. Pediatr. Adolesc. Gynecol."},{"key":"e_1_3_2_3_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpag.2007.05.001"},{"key":"e_1_3_2_3_19_1","first-page":"1265","article-title":"Pre- and postpuberal findings in premature adrenarche.","volume":"13","author":"DiMartino-Nardi J","year":"2000","unstructured":"DiMartino-Nardi J : Pre- and postpuberal findings in premature adrenarche.J. Pediatr. Endocrinol. Metab.13(Suppl. 5), 1265\u20131269(2000).","journal-title":"J. Pediatr. Endocrinol. Metab."},{"key":"e_1_3_2_3_20_1","first-page":"185","article-title":"Prediction models for insulin resistance in girls with premature adrenarche. The premature adrenarche insulin resistance score: PAIR score","volume":"65","author":"Vuguin P","year":"2006","unstructured":"Vuguin P , GrinsteinG, FreemanK, SaengerP, DiMartino Nardi J: Prediction models for insulin resistance in girls with premature adrenarche. The premature adrenarche insulin resistance score: PAIR score. Horm. Res.65, 185\u2013191(2006).","journal-title":"Horm. Res."},{"key":"e_1_3_2_3_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jadohealth.2008.02.003"},{"key":"e_1_3_2_3_22_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2006-2012"},{"key":"e_1_3_2_3_23_1","doi-asserted-by":"publisher","DOI":"10.1196\/annals.1429.024"},{"key":"e_1_3_2_3_24_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.95.25.14956"},{"key":"e_1_3_2_3_25_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2008-2836"},{"key":"e_1_3_2_3_26_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2005-2099"},{"key":"e_1_3_2_3_27_1","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-49-5-687"},{"key":"e_1_3_2_3_28_1","doi-asserted-by":"publisher","DOI":"10.1093\/humupd\/dml017"},{"key":"e_1_3_2_3_29_1","first-page":"2248","article-title":"Determinants of abnormal gonadotropin secretion in clinically defined women with polycystic ovary syndrome.","volume":"82","author":"Taylor AE","year":"1997","unstructured":"Taylor AE , McCourtB, MartinKAet al.: Determinants of abnormal gonadotropin secretion in clinically defined women with polycystic ovary syndrome.J. Clin. Endocrinol. Metab.82, 2248\u20132256(1997).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"e_1_3_2_3_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2009.02.072"},{"key":"e_1_3_2_3_31_1","first-page":"895","article-title":"Increased luteinizing hormone and \u03b1-subunit secretion in women with hyperandrogenic anovulation.","volume":"77","author":"Berga SL","year":"1993","unstructured":"Berga SL , GuzickDS, WintersSJ: Increased luteinizing hormone and \u03b1-subunit secretion in women with hyperandrogenic anovulation.J. Clin. Endocrinol. Metab.77, 895\u2013901(1993).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"e_1_3_2_3_32_1","first-page":"4047","article-title":"Polycystic ovarian syndrome: evidence that flutamide restores sensitivity of the gonadotropin-releasing hormone pulse generator to inhibition by estradiol and progesterone.","volume":"85","author":"Eagleson CA","year":"2000","unstructured":"Eagleson CA , GingrichMB, PastorCLet al.: Polycystic ovarian syndrome: evidence that flutamide restores sensitivity of the gonadotropin-releasing hormone pulse generator to inhibition by estradiol and progesterone.J. Clin. Endocrinol. Metab.85, 4047\u20134052(2000).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"e_1_3_2_3_33_1","doi-asserted-by":"publisher","DOI":"10.1210\/endo.140.4.6642"},{"key":"e_1_3_2_3_34_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2008-2606"},{"key":"e_1_3_2_3_35_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra041536"},{"key":"e_1_3_2_3_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0889-8529(05)70074-8"},{"key":"e_1_3_2_3_37_1","first-page":"2001","article-title":"Insulin stimulates testosterone biosynthesis by human thecal cells from women with polycystic ovary syndrome by activating its own receptor and using inositolglycan mediators as the signal transduction system","volume":"83","author":"Nestler JE","year":"1998","unstructured":"Nestler JE , JakubowiczDJ, de Vargas AF, Brik C, Quintero N, Medina F: Insulin stimulates testosterone biosynthesis by human thecal cells from women with polycystic ovary syndrome by activating its own receptor and using inositolglycan mediators as the signal transduction system. J. Clin. Endocrinol. Metab.83, 2001\u20132005(1998).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"e_1_3_2_3_38_1","doi-asserted-by":"crossref","unstructured":"Magoffin D : Ovarian Steroidogenic Abnormalities in the Polycystic Ovary Syndrome Humana Press NY USA (2007).","DOI":"10.1016\/j.fertnstert.2006.03.015"},{"key":"e_1_3_2_3_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ecl.2005.04.005"},{"key":"e_1_3_2_3_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0300-595X(86)80021-4"},{"key":"e_1_3_2_3_41_1","doi-asserted-by":"publisher","DOI":"10.2337\/dc08-1618"},{"key":"e_1_3_2_3_42_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0015-0282(16)56160-3"},{"key":"e_1_3_2_3_43_1","first-page":"904","article-title":"Does polycystic ovary syndrome start in childhood?","volume":"5","author":"Diamanti-Kandarakis E","year":"2008","unstructured":"Diamanti-Kandarakis E , ChristakouC, PaliouraE, KandarakiE, LivadasS: Does polycystic ovary syndrome start in childhood?Pediatr. Endocrinol. Rev.5, 904\u2013911(2008).","journal-title":"Pediatr. Endocrinol. Rev."},{"key":"e_1_3_2_3_44_1","doi-asserted-by":"publisher","DOI":"10.1515\/JPEM.2005.18.5.499"},{"key":"e_1_3_2_3_45_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2004.07.001"},{"key":"e_1_3_2_3_46_1","doi-asserted-by":"publisher","DOI":"10.1053\/beem.2002.0203"},{"key":"e_1_3_2_3_47_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpedi.162.6.521"},{"key":"e_1_3_2_3_48_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0015-0282(99)00641-X"},{"key":"e_1_3_2_3_49_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2004-2301"},{"key":"e_1_3_2_3_50_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2265.2002.01603.x"},{"key":"e_1_3_2_3_51_1","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-21-11-1440"},{"key":"e_1_3_2_3_52_1","doi-asserted-by":"publisher","DOI":"10.1093\/humupd\/dmp024"},{"key":"e_1_3_2_3_53_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2005.06527.x"},{"key":"e_1_3_2_3_54_1","doi-asserted-by":"publisher","DOI":"10.1530\/eje.0.1450619"},{"key":"e_1_3_2_3_55_1","first-page":"2513","article-title":"Adrenocortical secretion of dehydroepiandrosterone in healthy women: highly variable response to adrenocorticotropin","volume":"86","author":"Azziz R","year":"2001","unstructured":"Azziz R , FoxLM, ZacurHA, ParkerCR Jr, Boots LR: Adrenocortical secretion of dehydroepiandrosterone in healthy women: highly variable response to adrenocorticotropin. J. Clin. Endocrinol. Metab.86, 2513\u20132517(2001).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"e_1_3_2_3_56_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2008-2583"},{"key":"e_1_3_2_3_57_1","first-page":"69","article-title":"Dehydroepiandrosterone sulfate as an indicator of adrenal androgen function.","volume":"57","author":"Lobo RA","year":"1981","unstructured":"Lobo RA , PaulWL, GoebelsmannU: Dehydroepiandrosterone sulfate as an indicator of adrenal androgen function.Obstet. Gynecol.57, 69\u201373(1981).","journal-title":"Obstet. Gynecol."},{"key":"e_1_3_2_3_58_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199207163270304"},{"key":"e_1_3_2_3_59_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2265.1999.00886.x"},{"key":"e_1_3_2_3_60_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(88)91612-1"},{"key":"e_1_3_2_3_61_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1469-0705.1994.04010054.x"},{"key":"e_1_3_2_3_62_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2008-2771"},{"key":"e_1_3_2_3_63_1","doi-asserted-by":"publisher","DOI":"10.1159\/000140805"},{"key":"e_1_3_2_3_64_1","doi-asserted-by":"publisher","DOI":"10.1098\/rspb.1963.0055"},{"key":"e_1_3_2_3_65_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2006-0835"},{"key":"e_1_3_2_3_66_1","first-page":"3728","article-title":"Inappropriate gonadotropin secretion in polycystic ovary syndrome: influence of adiposity.","volume":"82","author":"Arroyo A","year":"1997","unstructured":"Arroyo A , LaughlinGA, MoralesAJ, YenSS: Inappropriate gonadotropin secretion in polycystic ovary syndrome: influence of adiposity.J. Clin. Endocrinol. Metab.82, 3728\u20133733(1997).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"e_1_3_2_3_67_1","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/17.10.2495"},{"key":"e_1_3_2_3_68_1","first-page":"2854","article-title":"Insulin, somatotropic, and luteinizing hormone axes in lean and obese women with polycystic ovary syndrome: common and distinct features.","volume":"81","author":"Morales AJ","year":"1996","unstructured":"Morales AJ , LaughlinGA, ButzowT, MaheshwariH, BaumannG, YenSS: Insulin, somatotropic, and luteinizing hormone axes in lean and obese women with polycystic ovary syndrome: common and distinct features.J. Clin. Endocrinol. Metab.81, 2854\u20132864(1996).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"e_1_3_2_3_69_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.1989.tb00446.x"},{"key":"e_1_3_2_3_70_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.105.169404"},{"key":"e_1_3_2_3_71_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2007.06.004"},{"key":"e_1_3_2_3_72_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(07)60958-1"},{"key":"e_1_3_2_3_73_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000145117.40114.C7"},{"key":"e_1_3_2_3_74_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2007-1549"},{"key":"e_1_3_2_3_75_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2005-1666"},{"key":"e_1_3_2_3_76_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2005-1707"},{"key":"e_1_3_2_3_77_1","doi-asserted-by":"publisher","DOI":"10.1067\/mpd.2001.109603"},{"key":"e_1_3_2_3_78_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2008-1198"},{"key":"e_1_3_2_3_79_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpedi.160.3.241"},{"key":"e_1_3_2_3_80_1","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.87.3.8305"},{"key":"e_1_3_2_3_81_1","first-page":"66","article-title":"Glucose intolerance in obese adolescents with polycystic ovary syndrome: roles of insulin resistance and \u03b2-cell dysfunction and risk of cardiovascular disease.","volume":"86","author":"Arslanian SA","year":"2001","unstructured":"Arslanian SA , LewyVD, DanadianK: Glucose intolerance in obese adolescents with polycystic ovary syndrome: roles of insulin resistance and \u03b2-cell dysfunction and risk of cardiovascular disease.J. Clin. Endocrinol. Metab.86, 66\u201371(2001).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"e_1_3_2_3_82_1","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.85.9.6814"},{"key":"e_1_3_2_3_83_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2003-030617"},{"key":"e_1_3_2_3_84_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-543X.2005.00097.x"},{"key":"e_1_3_2_3_85_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(01)00948-2"},{"key":"e_1_3_2_3_86_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2007.02849.x"},{"key":"e_1_3_2_3_87_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2008.06.004"},{"key":"e_1_3_2_3_88_1","doi-asserted-by":"publisher","DOI":"10.1196\/annals.1365.014"},{"key":"e_1_3_2_3_89_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2006.02587.x"},{"key":"e_1_3_2_3_90_1","first-page":"S33","article-title":"Obese adolescent girls with polycystic ovary syndrome (PCOS) have more severe insulin resistance measured by HOMA-IR score than obese girls without PCOS.","volume":"88","author":"Sawathiparnich P","year":"2005","unstructured":"Sawathiparnich P , WeerakulwattanaL, SantiprabhobJ, LikitmaskulS: Obese adolescent girls with polycystic ovary syndrome (PCOS) have more severe insulin resistance measured by HOMA-IR score than obese girls without PCOS.J. Med. Assoc. Thai.88(Suppl. 8), S33\u2013S37 (2005).","journal-title":"J. Med. Assoc. Thai."},{"key":"e_1_3_2_3_91_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2005.11.003"},{"key":"e_1_3_2_3_92_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.1992.tb02909.x"},{"key":"e_1_3_2_3_93_1","first-page":"2586","article-title":"Restored insulin sensitivity but persistently increased early insulin secretion after weight loss in obese women with polycystic ovary syndrome.","volume":"80","author":"Holte J","year":"1995","unstructured":"Holte J , BerghT, BerneC, WideL, LithellH: Restored insulin sensitivity but persistently increased early insulin secretion after weight loss in obese women with polycystic ovary syndrome.J. Clin. Endocrinol. Metab.80, 2586\u20132593(1995).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"e_1_3_2_3_94_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11325-009-0276-0"},{"key":"e_1_3_2_3_95_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-992928"},{"key":"e_1_3_2_3_96_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2004.02.104"},{"key":"e_1_3_2_3_97_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2008-0461"},{"key":"e_1_3_2_3_98_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2008.05.065"},{"key":"e_1_3_2_3_99_1","doi-asserted-by":"publisher","DOI":"10.1093\/ajcn\/84.1.77"},{"key":"e_1_3_2_3_100_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2002-020815"},{"key":"e_1_3_2_3_101_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2003.08.023"},{"key":"e_1_3_2_3_102_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2008-0751"},{"key":"e_1_3_2_3_103_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.beem.2006.03.003"},{"key":"e_1_3_2_3_104_1","first-page":"995","article-title":"The evaluation and management of hirsutism.","volume":"101","author":"Azziz R","year":"2003","unstructured":"Azziz R : The evaluation and management of hirsutism.Obstet. Gynecol.101, 995\u20131007(2003).","journal-title":"Obstet. Gynecol."},{"key":"e_1_3_2_3_105_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1473-2165.2008.00363.x"},{"key":"e_1_3_2_3_106_1","doi-asserted-by":"publisher","DOI":"10.1185\/030079905X56475"},{"key":"e_1_3_2_3_107_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10103-008-0583-x"},{"key":"e_1_3_2_3_108_1","doi-asserted-by":"publisher","DOI":"10.2165\/00128071-200102030-00009"},{"key":"e_1_3_2_3_109_1","doi-asserted-by":"publisher","DOI":"10.2147\/TCRM.S6864"},{"key":"e_1_3_2_3_110_1","first-page":"721","article-title":"YAZ and the novel progestin drospirenone","volume":"53","author":"Mishell DR","year":"2008","unstructured":"Mishell DR Jr: YAZ and the novel progestin drospirenone. J. Reprod. Med.53, 721\u2013728(2008).","journal-title":"J. Reprod. Med."},{"key":"e_1_3_2_3_111_1","first-page":"2","article-title":"The effect of 2 combined oral Contraceptives containing either drospirenone or cyproterone acetate on acne and seborrhea","volume":"69","author":"van Vloten WA","year":"2002","unstructured":"van Vloten WA , van Haselen CW, van Zuuren EJ, Gerlinger C, Heithecker R: The effect of 2 combined oral Contraceptives containing either drospirenone or cyproterone acetate on acne and seborrhea. Cutis69, 2\u201315(2002).","journal-title":"Cutis"},{"key":"e_1_3_2_3_112_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bpobgyn.2004.05.007"},{"key":"e_1_3_2_3_113_1","doi-asserted-by":"publisher","DOI":"10.1016\/0028-2243(87)90101-8"},{"key":"e_1_3_2_3_114_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-0528.1995.tb09070.x"},{"key":"e_1_3_2_3_115_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0029-7844(02)02056-2"},{"key":"e_1_3_2_3_116_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2005.07.1306"},{"key":"e_1_3_2_3_117_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0015-0282(02)02993-X"},{"key":"e_1_3_2_3_118_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-992931"},{"key":"e_1_3_2_3_119_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2003-031780"},{"key":"e_1_3_2_3_120_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2265.2000.00982.x"},{"key":"e_1_3_2_3_121_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2008.03472.x"},{"key":"e_1_3_2_3_122_1","doi-asserted-by":"publisher","DOI":"10.1093\/humupd\/dmi054"},{"key":"e_1_3_2_3_123_1","doi-asserted-by":"publisher","DOI":"10.1530\/eje.0.1410361"},{"key":"e_1_3_2_3_124_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2008.08.004"},{"key":"e_1_3_2_3_125_1","first-page":"CD003053","article-title":"Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility.","author":"Tang T","year":"2009","unstructured":"Tang T , LordJM, NormanRJ, YasminE, BalenAH: Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility.Cochrane Database Syst. Rev.CD003053 (2009).","journal-title":"Cochrane Database Syst. Rev."},{"key":"e_1_3_2_3_126_1","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.87.4.8398"},{"key":"e_1_3_2_3_127_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejogrb.2004.09.015"},{"key":"e_1_3_2_3_128_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2003.08.015"},{"key":"e_1_3_2_3_129_1","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/del185"},{"key":"e_1_3_2_3_130_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1054-139X(01)00202-6"},{"key":"e_1_3_2_3_131_1","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.86.8.7756"},{"key":"e_1_3_2_3_132_1","first-page":"3526","article-title":"Sensitization to insulin in adolescent girls to normalize hirsutism, hyperandrogenism, oligomenorrhea, dyslipidemia, and hyperinsulinism after precocious pubarche","volume":"85","author":"Ibanez L","year":"2000","unstructured":"Ibanez L , VallsC, PotauN, MarcosMV, de Zegher F: Sensitization to insulin in adolescent girls to normalize hirsutism, hyperandrogenism, oligomenorrhea, dyslipidemia, and hyperinsulinism after precocious pubarche. J. Clin. Endocrinol. Metab.85, 3526\u20133530(2000).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"e_1_3_2_3_133_1","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/deh440"},{"key":"e_1_3_2_3_134_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.ftd.0000184161.52573.0e"},{"key":"e_1_3_2_3_135_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.270.22.12953"},{"key":"e_1_3_2_3_136_1","doi-asserted-by":"publisher","DOI":"10.1155\/PPAR\/2006\/73986"},{"key":"e_1_3_2_3_137_1","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.25.4.708"},{"key":"e_1_3_2_3_138_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2826.2007.01634.x"},{"key":"e_1_3_2_3_139_1","first-page":"589","article-title":"Study on treatment of hyperandrogenism and hyperinsulinism in polycystic ovary syndrome with Chinese herbal formula \u2018tiangui fang\u2019.","volume":"20","author":"Hou J","year":"2000","unstructured":"Hou J , YuJ, WeiM: Study on treatment of hyperandrogenism and hyperinsulinism in polycystic ovary syndrome with Chinese herbal formula \u2018tiangui fang\u2019.Zhongguo Zhong Xi Yi Jie He Za Zhi20, 589\u2013592(2000).","journal-title":"Zhongguo Zhong Xi Yi Jie He Za Zhi"},{"key":"e_1_3_2_3_140_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11010-008-9744-2"},{"key":"e_1_3_2_3_141_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-985847"},{"key":"e_1_3_2_3_142_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejogrb.2009.09.008"},{"key":"e_1_3_2_3_143_1","first-page":"CD001122","article-title":"Laparoscopic \u2018drilling\u2019 by diathermy or laser for ovulation induction in anovulatory polycystic ovary syndrome.","author":"Farquhar C","year":"2007","unstructured":"Farquhar C , LilfordRJ, MarjoribanksJ, VandekerckhoveP: Laparoscopic \u2018drilling\u2019 by diathermy or laser for ovulation induction in anovulatory polycystic ovary syndrome.Cochrane Database Syst. Rev.CD001122 (2007).","journal-title":"Cochrane Database Syst. Rev."},{"key":"e_1_3_2_4_2_1","unstructured":"Medical eligibility criteria for contraceptive use. Third edition. 2004. www.who.int\/reproductivehealth\/publications\/mec\/index.htm"}],"container-title":["Pediatric Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.2217\/phe.09.69","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T14:40:49Z","timestamp":1715956849000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.2217\/phe.09.69"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,1,25]]},"references-count":144,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,2]]}},"alternative-id":["10.2217\/phe.09.69"],"URL":"https:\/\/doi.org\/10.2217\/phe.09.69","relation":{},"ISSN":["1745-5111","1745-512X"],"issn-type":[{"value":"1745-5111","type":"print"},{"value":"1745-512X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,1,25]]}}}